» Articles » PMID: 38171211

The Diagnostic Role of Repeated Biopsy of Thyroid Nodules with Atypia of Undetermined Significance with Architectural Atypia on Core-Needle Biopsy

Overview
Specialty Endocrinology
Date 2024 Jan 3
PMID 38171211
Authors
Affiliations
Soon will be listed here.
Abstract

Backgruound: We aimed to evaluate the utility of repeat biopsy of thyroid nodules classified as atypia of undetermined significance with architectural atypia (IIIB) on core-needle biopsy (CNB).

Methods: This retrospective study evaluated patients with thyroid nodules categorized as IIIB on CNB between 2013 and 2015. Demographic characteristics, subsequent biopsy results, and ultrasound (US) images were evaluated. The malignancy rates of nodules according to number of CNBs and the number of IIIB diagnoses was compared. Demographic and US features were evaluated to determine factors predictive of malignancy.

Results: Of 1,003 IIIB nodules on CNB, the final diagnosis was determined for 328 (32.7%) nodules, with 121 of them confirmed as malignant, resulting in a malignancy rate of 36.9% (95% confidence interval, 31.7% to 42.1%). Repeat CNB was performed in 248 nodules (24.7%), with 75 (30.2%), 131 (52.8%), 13 (5.2%), 26 (10.5%), one (0.4%), and two (0.8%) reclassified into categories II, IIIB, IIIA, IV, V, and VI, respectively. Malignancy rates were not significantly affected by the number of CNBs (P=0.291) or the number of IIIB diagnoses (P=0.473). None of the nodules confirmed as category II on repeat CNB was malignant. US features significantly associated with malignancy (P<0.003) included solid composition, irregular margins, microcalcifications, and high suspicion on the US risk stratification system.

Conclusion: Repeat biopsy of nodules diagnosed with IIIB on CNB did not increase the detection of malignancy but can potentially reduce unnecessary surgery. Repeat biopsy should be performed selectively, with US features guiding the choice between repeat biopsy and diagnostic surgery.

References
1.
Choi S, Baek J, Lee J, Choi Y, Hong M, Song D . Thyroid nodules with initially non-diagnostic, fine-needle aspiration results: comparison of core-needle biopsy and repeated fine-needle aspiration. Eur Radiol. 2014; 24(11):2819-26. DOI: 10.1007/s00330-014-3325-4. View

2.
Jung C . Reevaluating diagnostic categories and associated malignancy risks in thyroid core needle biopsy. J Pathol Transl Med. 2023; 57(4):208-216. PMC: 10369141. DOI: 10.4132/jptm.2023.06.20. View

3.
Straccia P, Rossi E, Bizzarro T, Brunelli C, Cianfrini F, Damiani D . A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?. Cancer Cytopathol. 2015; 123(12):713-22. DOI: 10.1002/cncy.21605. View

4.
Screaton N, Berman L, Grant J . US-guided core-needle biopsy of the thyroid gland. Radiology. 2003; 226(3):827-32. DOI: 10.1148/radiol.2263012073. View

5.
Kuru B, Atmaca A, Tarim I, Kefeli M, Topgul K, Yoruker S . Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS). Eur J Surg Oncol. 2015; 42(1):87-93. DOI: 10.1016/j.ejso.2015.09.026. View